Adaptive Biotechnologies Corp (ADPT): Next-Year EPS Estimate 46.56%
As of 2026-06-11, Adaptive Biotechnologies Corp (ADPT) has a next-year EPS growth estimate of 46.56%.
ADPT was first flagged by our screen on 2026-06-07, when analyst consensus for its next-year EPS growth was revised from 46.09% to 46.56%. Current-year growth is projected at -18.27%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- EPS growth next year
- 46.56%
- EPS growth this year
- -18.27%
- EPS next quarter (est)
- -$0.13
- Last price
- $18.73
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 46.56% | -18.27% | -$0.13 | $18.73 |
| 2026-06-10 | 46.56% | -18.27% | -$0.13 | $17.07 |
| 2026-06-09 | 46.56% | -18.27% | -$0.13 | $17.36 |
| 2026-06-08 | 46.56% | -18.27% | -$0.13 | $16.70 |
| 2026-06-07 | 46.56% | -18.27% | -$0.13 | $16.90 |
| 2026-06-04 | 46.09% | -18.91% | -$0.14 | $18.08 |
| 2026-06-03 | 46.09% | -18.91% | -$0.14 | $15.99 |
| 2026-06-02 | 46.09% | -18.91% | -$0.14 | $15.14 |
| 2026-06-01 | 47.04% | -19.23% | -$0.14 | $15.23 |
| 2026-05-31 | 47.04% | -19.23% | -$0.14 | $15.15 |
| 2026-05-28 | 47.04% | -19.23% | -$0.14 | $15.19 |
| 2026-05-27 | 47.04% | -19.23% | -$0.14 | $13.84 |
| 2026-05-26 | 47.04% | -19.23% | -$0.14 | $14.13 |
| 2026-05-25 | 47.04% | -19.23% | -$0.14 | $13.88 |
| 2026-05-24 | 47.04% | -19.23% | -$0.14 | $13.88 |
| 2026-05-21 | 47.04% | -19.23% | -$0.14 | $13.87 |
| 2026-05-20 | 47.04% | -19.23% | -$0.14 | $13.96 |
| 2026-05-19 | 47.04% | -19.23% | -$0.14 | $12.96 |
| 2026-05-18 | 47.31% | -19.23% | -$0.14 | $12.71 |
| 2026-05-17 | 47.31% | -19.23% | -$0.14 | $12.83 |
| 2026-05-14 | 46.52% | -19.87% | -$0.14 | $13.18 |
| 2026-05-13 | 46.52% | -19.87% | -$0.14 | $13.02 |
| 2026-05-12 | 46.52% | -19.87% | -$0.14 | $13.63 |
| 2026-05-11 | 45.17% | -22.76% | -$0.14 | $13.54 |
| 2026-05-10 | 45.17% | -22.76% | -$0.14 | $13.81 |
| 2026-05-07 | 45.17% | -22.76% | -$0.14 | $14.69 |
| 2026-05-06 | 45.17% | -22.76% | -$0.14 | $14.43 |
| 2026-05-05 | 45.55% | -24.31% | -$0.16 | $13.78 |
| 2026-05-04 | 45.55% | -24.31% | -$0.16 | $14.50 |
| 2026-05-03 | 45.55% | -24.31% | -$0.16 | $14.27 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Adaptive Biotechnologies Corp's next-year EPS growth estimate?▾
As of 2026-06-11, Adaptive Biotechnologies Corp (ADPT) has a next-year EPS growth estimate of 46.56%, based on analyst consensus.
When was the latest EPS estimate revision for ADPT?▾
The most recent revision occurred on 2026-06-07, when analysts adjusted the next-year EPS growth estimate from 46.09% to 46.56%.
What sector and industry does Adaptive Biotechnologies Corp belong to?▾
Adaptive Biotechnologies Corp operates in the Healthcare sector, specifically the Diagnostics & Research industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ADPT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Adaptive Biotechnologies Corp (ADPT) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports